MD Andrson Cancer Center — Houston, Texas

MD Andrson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

MD Andrson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Acute Myeloid Leukemia.

Sponsors: Cornerstone Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Andrson Cancer Center?

MD Andrson Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Andrson Cancer Center conducted?

MD Andrson Cancer Center has 1 clinical trials on record. Their work covers Relapsed/Refractory Acute Myeloid Leukemia.

Is MD Andrson Cancer Center accredited by Crixeo Health?

MD Andrson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Andrson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.